Inquis Medical raised $40M in a Series B financing led by Marshall Wace to advance the Aventus Thrombectomy System for venous thromboembolic diseases.
Inquis Medical raised $40M in a Series B financing led by Marshall Wace to advance the Aventus Thrombectomy System for venous thromboembolic diseases.
11/04/24, 7:54 PM
Location
menlo parkMoney raised
$40 million
Industry
medical device
medical
biotechnology
health care
Round Type
series b
Investors
Pierre Lamond, En Pointe Ventures, Yu Star, Shang Bay Capital, Marshall Wace
Inquis Medical has successfully closed a $40 million Series B financing round, led by Marshall Wace. This funding will help accelerate the development and commercialization of their advanced thrombectomy technologies.
Company Info
Location
menlo park, california, united states
Additional Info
Inquis Medical is a clinical-stage medical device company focused on peripheral vascular innovations. The company is developing next generation thrombectomy technology that offers physicians improved control and precision, enhances procedural efficiency, and minimizes blood loss. Founded in 2020, Inquis Medical is led by a seasoned executive team with over three decades of combined experience in developing, launching, and supporting novel medical devices that address unmet clinical needs and deliver lasting impact.